XML 106 R62.htm IDEA: XBRL DOCUMENT v3.20.4
Significant agreements - Collaboration revenues (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Significant agreements.                      
Collaboration revenues $ 3,848 $ 3,842 $ 1,571 $ 1,129 $ 5,281 $ 614 $ 1,522 $ 6,384 $ 10,390 $ 13,801 $ 7,136
AstraZeneca                      
Significant agreements.                      
Collaboration revenues                 2,696 1,683 1,386
Sanofi                      
Significant agreements.                      
Collaboration revenues                 0 10,724 4,007
Oxurion                      
Significant agreements.                      
Collaboration revenues                 2,362 0 $ 1,743
Dementia Discovery Fund                      
Significant agreements.                      
Collaboration revenues                 436 394  
Material transfer agreement                      
Significant agreements.                      
Collaboration revenues                 0 $ 1,000  
Genentech                      
Significant agreements.                      
Collaboration revenues                 $ 4,896